Mankind Pharma Agrees to Acquire 70% of Belgium’s ACTx for €48 Million
Mankind Pharma agreed to acquire a 70% stake in Belgium-based Armed Cell Therapeutics for €48 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.